A framework for economic evaluation of therapeutic drug monitoring—guided dosing in oncology
Abstract The standard approach for dose individualization of chemotherapy in the oncology setting has long been based on body surface area (BSA) as a measure of body size. However, for many anticancer drugs, administration of dosages based on BSA may result in some patients receiving supratherapeuti...
Enregistré dans:
Auteurs principaux: | Daniel Erku, Jennifer Schneider, Paul Scuffham |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4cb74d7419184c139d1f9e507ac548a9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
par: Dreesen E, et autres
Publié: (2017) -
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
par: Feng Z, et autres
Publié: (2021) -
A framework to guide dose & regimen strategy for clinical drug development
par: Oliver Sander, et autres
Publié: (2021) -
Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
par: Kashif Hussain, et autres
Publié: (2021) -
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
par: Christoph Tiede, et autres
Publié: (2021)